[Treatment of airway obstruction by catecholamines and atropine].
D000368:Aged; D000402:Airway Obstruction / Q000188:drug therapy*; D000403:Airway Resistance / Q000187:drug effects; D001285:Atropine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001982:Bronchial Diseases / Q000188:drug therapy*; D002245:Carbon Dioxide / Q000097:blood; D002908:Chronic Disease; D002940:Circadian Rhythm; D005260:Female; D006801:Humans; D008297:Male; D009921:Metaproterenol / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D009662:Nortropanes / Q000627:therapeutic use*; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D011437:Propylamines / Q000627:therapeutic use; D012138:Respiratory Therapy; D013147:Spirometry; D013997:Time Factors
D009662:Nortropanes; D011437:Propylamines; D002245:Carbon Dioxide; D009921:Metaproterenol; D001285:Atropine; D010100:Oxygen
Beeinflussung der Atemwegsobstruktion durch kombinierte Katecholamin-Atropin-Therapie.